Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03574779
Title Phase 2 Multicohort Study to Evaluate the Safety and Efficacy of Novel Treatment Combinations in Patients With Recurrent Ovarian Cancer (OPAL)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

ovary epithelial cancer

ovarian carcinosarcoma

peritoneum cancer

fallopian tube cancer

Therapies

Bevacizumab + Dostarlimab + Niraparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.